Vemurafenib Oral Tablet [Zelboraf]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
- 2014
Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic… (More)
Is this relevant?
2011
2011
- Nature Biotechnology
- 2011
Two novel cancer drugs and their companion diagnostics to predict treatment response were given a go-ahead to market in quick… (More)
Is this relevant?